nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—Venlafaxine—ABCB1—adrenal gland cancer	0.0729	0.695	CrCbGaD
Tramadol—Dextromethorphan—ABCB1—adrenal gland cancer	0.0319	0.305	CrCbGaD
Tramadol—OPRK1—GPCR ligand binding—TSHR—adrenal gland cancer	0.0041	0.00458	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00394	0.0044	CbGpPWpGaD
Tramadol—OPRK1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00394	0.0044	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00391	0.00437	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00389	0.00434	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00378	0.00422	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00371	0.00414	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00367	0.0041	CbGpPWpGaD
Tramadol—OPRD1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00359	0.00401	CbGpPWpGaD
Tramadol—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00354	0.00396	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00347	0.00387	CbGpPWpGaD
Tramadol—CYP2B6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00345	0.00385	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00336	0.00376	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00334	0.00373	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00333	0.00372	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00333	0.00372	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00315	0.00352	CbGpPWpGaD
Tramadol—OPRK1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00314	0.00351	CbGpPWpGaD
Tramadol—OPRD1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00303	0.00338	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—TSHR—adrenal gland cancer	0.00298	0.00332	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00297	0.00331	CbGpPWpGaD
Tramadol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00295	0.0033	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00287	0.00321	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00286	0.0032	CbGpPWpGaD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00275	0.00307	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00272	0.00304	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00271	0.00303	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00269	0.00301	CbGpPWpGaD
Tramadol—OPRM1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00266	0.00297	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00266	0.00297	CbGpPWpGaD
Tramadol—OPRK1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00265	0.00296	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00264	0.00295	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0026	0.0029	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00256	0.00286	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00247	0.00276	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00246	0.00275	CbGpPWpGaD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00241	0.00269	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—TSHR—adrenal gland cancer	0.0024	0.00268	CbGpPWpGaD
Tramadol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00239	0.00268	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00239	0.00266	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00236	0.00264	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00236	0.00263	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00233	0.0026	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00232	0.00259	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00232	0.00259	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00224	0.0025	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0022	0.00245	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00216	0.00242	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00211	0.00236	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—TSHR—adrenal gland cancer	0.0021	0.00235	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00205	0.00229	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00204	0.00227	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00202	0.00225	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.002	0.00223	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00197	0.0022	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00196	0.00219	CbGpPWpGaD
Tramadol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00193	0.00216	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.0019	0.00212	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00189	0.00211	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—POMC—adrenal gland cancer	0.00183	0.00205	CbGpPWpGaD
Tramadol—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	0.00183	0.00204	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00183	0.00204	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00178	0.00199	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00178	0.00199	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—GNAS—adrenal gland cancer	0.00173	0.00193	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00172	0.00192	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00172	0.00192	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00171	0.00191	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GNRHR—adrenal gland cancer	0.00169	0.00189	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00168	0.00188	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00166	0.00186	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—SDHB—adrenal gland cancer	0.00164	0.00183	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00163	0.00182	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00162	0.00181	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00161	0.0018	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—POMC—adrenal gland cancer	0.00161	0.00179	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00159	0.00178	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00157	0.00175	CbGpPWpGaD
Tramadol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00157	0.00175	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00154	0.00172	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00153	0.00171	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—TSHR—adrenal gland cancer	0.00153	0.00171	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00151	0.00169	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—TP53—adrenal gland cancer	0.00149	0.00167	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00149	0.00166	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00148	0.00165	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00148	0.00165	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00146	0.00163	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00145	0.00163	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00145	0.00163	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00145	0.00162	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TSHR—adrenal gland cancer	0.00142	0.00158	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00141	0.00158	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—GNAS—adrenal gland cancer	0.0014	0.00156	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00139	0.00156	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00136	0.00152	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00135	0.00151	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00135	0.00151	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00135	0.00151	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MEN1—adrenal gland cancer	0.00133	0.00149	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00132	0.00147	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00131	0.00147	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00128	0.00143	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00128	0.00143	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00128	0.00142	CbGpPWpGaD
Tramadol—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.00127	0.00142	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00127	0.00142	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TSHR—adrenal gland cancer	0.00124	0.00139	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.00123	0.00137	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.00123	0.00137	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00122	0.00137	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00119	0.00133	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00118	0.00132	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MEN1—adrenal gland cancer	0.00117	0.00131	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00117	0.00131	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—POMC—adrenal gland cancer	0.00117	0.0013	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00114	0.00127	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.00114	0.00127	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0011	0.00122	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00108	0.00121	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00108	0.0012	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—SDHD—adrenal gland cancer	0.00105	0.00118	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—RRM1—adrenal gland cancer	0.00105	0.00118	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.00105	0.00117	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00104	0.00116	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00103	0.00116	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00102	0.00114	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00102	0.00114	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.00101	0.00113	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00101	0.00112	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.001	0.00112	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.000988	0.0011	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000978	0.00109	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000944	0.00105	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—POMC—adrenal gland cancer	0.00094	0.00105	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.00093	0.00104	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.000926	0.00103	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—MED12—adrenal gland cancer	0.000914	0.00102	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000908	0.00101	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TSHR—adrenal gland cancer	0.000902	0.00101	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000892	0.000997	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.000888	0.000992	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000882	0.000985	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.000872	0.000974	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CDC42—adrenal gland cancer	0.000863	0.000964	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MEN1—adrenal gland cancer	0.000848	0.000948	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000842	0.000941	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IGF2—adrenal gland cancer	0.000832	0.000929	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000832	0.000929	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—GNAS—adrenal gland cancer	0.000825	0.000921	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—POMC—adrenal gland cancer	0.000824	0.000921	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000804	0.000898	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.000801	0.000894	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000797	0.00089	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—MED12—adrenal gland cancer	0.000786	0.000878	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.000777	0.000868	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000767	0.000857	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.000765	0.000854	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDC42—adrenal gland cancer	0.000757	0.000845	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000754	0.000842	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000744	0.000831	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000733	0.000819	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000733	0.000819	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.00073	0.000816	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IGF2—adrenal gland cancer	0.000729	0.000815	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GNAS—adrenal gland cancer	0.000723	0.000808	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000705	0.000788	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000697	0.000778	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TERT—adrenal gland cancer	0.000692	0.000773	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.000667	0.000745	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000659	0.000736	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000648	0.000723	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.00064	0.000714	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000616	0.000689	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000611	0.000683	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TERT—adrenal gland cancer	0.000607	0.000678	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—BAD—adrenal gland cancer	0.000602	0.000673	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000598	0.000668	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000596	0.000666	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	0.000574	0.000641	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000567	0.000634	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000558	0.000623	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—POMC—adrenal gland cancer	0.000555	0.00062	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000549	0.000614	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—BRAF—adrenal gland cancer	0.000548	0.000612	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000546	0.00061	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.00054	0.000604	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000531	0.000594	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.00053	0.000592	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000529	0.000591	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—BAD—adrenal gland cancer	0.000528	0.00059	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000525	0.000586	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000515	0.000575	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000513	0.000573	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000512	0.000572	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—POMC—adrenal gland cancer	0.000487	0.000544	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—BRAF—adrenal gland cancer	0.000481	0.000537	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000479	0.000535	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000479	0.000535	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000473	0.000528	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000466	0.000521	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GNAS—adrenal gland cancer	0.000465	0.000519	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	0.000456	0.00051	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000456	0.000509	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000452	0.000505	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000446	0.000499	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000441	0.000492	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	0.000441	0.000492	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000412	0.00046	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000406	0.000454	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000399	0.000445	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000396	0.000443	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000394	0.00044	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	0.000383	0.000428	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000379	0.000424	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000364	0.000406	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000357	0.000399	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	0.000353	0.000395	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000349	0.00039	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000347	0.000388	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000338	0.000378	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.00033	0.000369	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000323	0.000361	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000317	0.000354	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—adrenal gland cancer	0.000314	0.000351	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—POMC—adrenal gland cancer	0.000313	0.00035	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000304	0.00034	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.0003	0.000336	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000294	0.000328	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000291	0.000325	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.00029	0.000324	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—adrenal gland cancer	0.000275	0.000308	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—adrenal gland cancer	0.000264	0.000294	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000261	0.000291	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000252	0.000282	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	0.00025	0.000279	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000233	0.00026	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—adrenal gland cancer	0.000231	0.000258	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000218	0.000243	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000217	0.000243	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000211	0.000236	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000207	0.000232	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	0.0002	0.000223	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000195	0.000218	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	0.000174	0.000194	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000172	0.000192	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	0.000168	0.000187	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000144	0.000161	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000142	0.000159	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.000113	0.000127	CbGpPWpGaD
